Original Article

You have free access to this content

Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions

  1. Angelique W. Levi MD†,*,
  2. Malini Harigopal MD,
  3. Pei Hui MD, PhD,
  4. Kevin Schofield CT (ASCP),
  5. David C. Chhieng MD, MBA

Article first published online: 5 JUL 2011

DOI: 10.1002/cncy.20172

Issue

Cancer Cytopathology

Cancer Cytopathology

Volume 119, Issue 4, pages 228–234, 25 August 2011

Additional Information

How to Cite

Levi, A. W., Harigopal, M., Hui, P., Schofield, K. and Chhieng, D. C. (2011), Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions. Cancer Cytopathology, 119: 228–234. doi: 10.1002/cncy.20172

Author Information

  1. Department of Pathology, Yale University, New Haven, Connecticut

  1. †

    Fax: (203) 737-5388

*Department of Pathology, Yale University, 430 Congress Ave, New Haven, CT 06519

Publication History

  1. Issue published online: 12 AUG 2011
  2. Article first published online: 5 JUL 2011
  3. Manuscript Accepted: 9 MAY 2011
  4. Manuscript Revised: 18 APR 2011
  5. Manuscript Received: 30 JAN 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (122K)

REFERENCES

  • 1
    Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst. 2000; 92: 397-402.
  • 2
    Ronco G, Cuzick J, Segnan N, et al. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer. 2007; 43: 476-480.
  • 3
    Thrall MJ, Smith DA, Mody DR. Women > or =30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women? Diagn Cytopathol. 2009; 38: 407-412.
  • 4
    Moss S, Gray A, Legood R, et al. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ. 2006; 332: 83-85.
  • 5
    Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med. 2009; 13: 648-659.
    Direct Link:
  • 6
    Sherman ME, Schiffman M, Cox JT; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002; 94: 102-107.
  • 7
    Castle PE, Fetterman B, Thomas Cox J, et al. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer. Obstet Gynecol. 2010; 116: 76-84.
  • 8
    Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006; 98: 765-774.
  • 9
    Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998; 92( 4 pt 2): 727-735.
  • 10
    Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004; 191: 105-113.
  • 11
    Tarkkanen J, Auvinen E, Nieminen P, et al. HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland. Acta Obstet Gynecol Scand. 2007; 86: 367-372.
    Direct Link:
  • 12
    Wright TCJr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007; 197: 346-355.
  • 13
    Zhao C, Zhao S, Heider A, Austin RM. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities. Arch Pathol Lab Med. 2010; 134: 1130-1135.
  • 14
    Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol. 2001; 83: 95-99.
  • 15
    Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet. 2002; 76: 41-47.
  • 16
    Moriarty AT, Schwartz MR, Eversole G, et al. Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006. Arch Pathol Lab Med. 2008; 132: 1290-1294.
View Full Article (HTML) Get PDF (122K)